Professor, Fudan University

Research Area: neuroscience, glia, microglia, neuroimmunology

Award Citation: The AYSF Committee celebrates his pioneering work in microglial cell replacement therapy, recognizing its transformative potential for neurodegenerative diseases. His innovative, bench-to-bedside approach promises to redefine treatment paradigms for debilitating neurological disorders and exemplifies the bold, translational science the committee is proud to support.

Bio: Bo Peng is a professor at Fudan University. He has been honored as a Distinguished Professor under the Chang Jiang Scholars Program by the Ministry of Education, China. He has received numerous awards, including the Asian Young Scientist Fellowship, Zhong Nanshan Youth Science and Technology Innovation Award and the Huaxia Medical Science and Technology Youth Award.

Prof. Peng’s research is centered on microglia in the central nervous system, with a particular focus on elucidating mechanisms of microglial turnover. Based on these insights, he has pioneered a novel therapeutic strategy involving microglia replacement for the treatment of neurological disorders, and in 2020, his team achieved the world’s first efficient microglia replacement. Furthermore, his group conducted the world’s first clinical trial of microglia replacement therapy in 2025, demonstrating its effectiveness and paving a new path for treating neurological diseases. His key research findings have been published as a last author in Science (2025), Nature Neuroscience (2018), Nature Aging (2023), Neuron (2021), Cell Reports (2020), Nature Communications (2022), and eLife (2023).

Personal Web: http://itbr.fudan.edu.cn/en/info/1181/2337.htm